# Lilly del Caribe, Inc. – FDA Inspection, Feb 17, 2023

Source: https://www.keypedia.com/records/fda_inspections/lilly-del-caribe-inc/c2c92c4c-c540-4128-90a5-30550b167b83
Source feed: FDA_Inspections

> FDA inspection 1198613 of Lilly del Caribe, Inc., February 17, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1198613
- Company Name: Lilly del Caribe, Inc.
- Inspection Date: 2023-02-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1321482 - 2026-05-12
- FDA Inspection 1069980 - 2018-09-27
- FDA Inspection 974723 - 2016-06-01
- FDA Inspection 868382 - 2014-02-21
- FDA Inspection 776200 - 2012-04-04

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/angelica-m-hernandez/d66d920c-01b6-4770-a1b5-cac9a1790a0e)
- [Issuing Officer](https://www.keypedia.com/people/jose-f-velez/0d1951e8-3aa5-48ff-bc54-1fae8a7a57c9)
- [Company Rep](https://www.keypedia.com/people/marian-e-ramirez/4b718b67-fee0-488c-9354-ee366d3510ad)

Company: https://www.keypedia.com/companies/lilly-del-caribe-inc/7961ecde-19e4-4ccc-9701-c1979bc57aaa

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c